| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| CD200 | Human CD200 / OX-2 Protein, His Tag, low endotoxin | Human | HEK293 | ![]() | SDS-PAGE | $300.00 100ug | |||
| CD200 | Human CD200 / OX-2 Protein, Fc Tag, low endotoxin | Human | HEK293 | ![]() | SDS-PAGE | $275.00 100ug | |||
| CD200 | Avitag OX2-H82F1 | Biotinylated Human CD200 / OX-2 Protein, Fc,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | ||
| CD200 | Avitag OX2-M82F3 | Biotinylated Mouse CD200 / OX-2 Protein, Fc,Avitag™ (MALS verified) | Mouse | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| P-006 | 23ME-00610; P-006; 23ME’610 | Phase 2 Clinical | 23andme Inc | Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Fallopian Tube Neoplasms; Microsatellite instability-high cancer; Neuroendocrine Tumors; Peritoneal Neoplasms; Small Cell Lung Carcinoma; Solid tumours | Details |